Samsung Bioepis Co., Ltd. today announced the relaunch of BYOOVIZ ® (ranibizumab-nuna) in the United States (US), in partnership with Harrow (Nasdaq: HROW). Harrow became responsible for ...

Islamabad: Former Pakistan Prime Minister Imran Khan and his wife Bushra Bibi have approached the country's Supreme Court ...

Appointment of experienced executive forms part of the Company’s strategy to build momentum across its proprietary platform ...

Samsung Bioepis Co., Ltd. announced the relaunch of Byooviz (ranibizumab-nuna) in the United States (US), in partnership with Harrow. Harrow became responsible for commercialization of Byooviz ...

Eyepoint Pharmaceuticals (NASDAQ:EYPT) executives said the company remains on track to report top-line data from its Phase 3 wet age-related macular degeneration program for DURAVYU, also known as EYP ...

Colorado Retina Associates is proud to announce that Dr. Jesse Smith, an experienced, board-certified retina specialist and ...

A single injection of sura-vec reduced the severity of nonproliferative diabetic retinopathy for up to 2 years, according to ...

Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced the commercial launch of BYOOVIZ® (ranibizumab-nuna), an FDA-approved biosimilar ...

FRONT-2 enrolled treatment-naïve and recently diagnosed treatment-experienced wet AMD patients, unlike the ...

The FDA approved Lumvoa, a full insulin-like growth factor 1 receptor antagonist, for the treatment of thyroid eye disease, ...

Researchers at the University of Massachusetts Amherst are using eye-tracking technology to help understand how nurses ...

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...